ABNX — Abionyx Pharma SA Cashflow Statement
0.000.00%
Last trade - 00:00- €35.17m
- €34.45m
- €4.64m
Annual cashflow statement for Abionyx Pharma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.85 | -1.89 | -5.82 | -4.21 | -3.52 |
| Depreciation | |||||
| Non-Cash Items | -4.86 | -0.865 | 0.755 | 0.615 | -0.871 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.954 | 2.13 | -1.74 | 0.097 | 0.538 |
| Change in Prepaid Expenses | |||||
| Change in Taxes Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -3.95 | -0.599 | -6.69 | -3.36 | -3.7 |
| Capital Expenditures | 0 | -0.148 | -0.166 | -0.175 | -0.13 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0.023 | 1.5 | — | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | 0 | -0.125 | 1.34 | -0.175 | -0.13 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.823 | 1.55 | 3.97 | -0.194 | 3.89 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.13 | 0.823 | -1.38 | -3.73 | 0.058 |